National Vision Holdings Option Alert: Jul 18 $22.5 Calls at the Ask: 2480 vs 8612 OI; Earnings 8/6 Before Open [est] 

National Vision Holdings Option Alert: Jul 18 $22.5 Calls at the Ask: 2480 @ $2.5 vs 8612 OI; Earnings 8/6 Before Open [est] Ref=$24.75

National Vision Holdings Azioni (NASDAQ: EYE)

National Vision Holdings (NASDAQ:EYE) Azioni

National Vision Holdings

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

National Vision Holdings, Inc. - Common Stock

National Vision Holdings Inc

AB Corporate Bond ETF

Eyenovia Inc

EYEFI Group Technologies Inc Ordinary Shares

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals Inc

Eyecity.com Inc

EYES ON THE GO INC by Eyes on the Go, Inc.

Eyes on the Go Inc

<p><a href="https://blog.google/products/search/deep-search-business-calling-google-search/">https://blog.google/products/search/deep-search-business-calling-google-search/</a></p>


News

General

GOOG

GOOGL

'More advanced AI capabilities are coming to Search'- Blog

<p>Wells Fargo  analyst Mike Mayo   maintains Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) with a Overweight and raises the price target from $110 to $115.</p>


Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Citigroup, Raises Price Target to $115

<p>Shares of <strong>Circle Internet Group Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), the digital finance company behind the <strong>$USDC</strong> stablecoin, are surging in Wednesday trading following a legislative reversal in Washington. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/CRCL/news">need to know</a>.</p>
<p><strong>What To Know:</strong> The rally ignited after President <strong>Donald Trump</strong> <a href="https://www.benzinga.com/news/politics/25/07/46435915/trump-says-11-of-12-republicans-needed-now-support-stablecoin-bill-after-earlier-setback-theyve-all-agreed-to-vote-in-favor">announced</a> he had secured the necessary support to advance a pivotal stablecoin bill just one day after it was blocked in a procedural vote.</p>
<p>The positive momentum marks a sharp turnaround from Tuesday when the House of Representatives failed to advance key crypto legislation, including the <strong>GENIUS Act</strong>. The procedural vote failed 198 to 223, casting doubt on the future of what was dubbed &#8220;Crypto Week.&#8221; </p>
<p>The setback was <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46433854/trumps-happy-crypto-week-gets-off-to-rocky-start-as-house-suspends-votes-on-key-bills">attributed</a> to several Republicans voting no due to disputes over amendments, including a proposed ban on a Central Bank Digital Currency.</p>
<p>Overnight, however, Trump announced on social media that he met with 11 of the dissenting lawmakers, who have now agreed to vote in favor of advancing the bill. </p>
<p>The GENIUS Act is crucial for Circle as it aims to establish the first comprehensive U.S. regulatory framework for dollar-pegged stablecoins. Renewed hopes for its passage are providing a significant boost to investor confidence in Circle's future.</p>
<p><strong>Analyst Ratings:</strong> The legislative momentum comes amid a flurry of <a href="https://www.benzinga.com/quote/CRCL/analyst-ratings">analyst coverage</a> on Circle. Wall Street has initiated coverage with a wide dispersion of ratings and price targets, reflecting varied outlooks on the company&#8217;s future. </p>
<p>On the bullish side, Needham initiated with a Buy rating and a $250 price target, while Barclays began coverage with an &#8216;Overweight&#8217; rating and a $215 target. Conversely, more cautious views have also emerged, with JP Morgan initiating at &#8216;Underweight&#8217; with an $80 target and Mizuho starting with an Underperform rating and an $85 target. </p>
<p>Other major firms, including Goldman Sachs and Baird, have taken a neutral stance, highlighting the market&#8217;s mixed expectations as the company navigates the critical regulatory landscape.</p>
<p><strong>Price Action:</strong> According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CRCL shares are trading higher by 12.8% to $220.17 Wednesday morning. The stock has a 52-week high of $298.99 and a 52-week low of $64.00.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46432984/circle-ceo-stablecoins-are-going-mainstream-fast">Circle CEO: Stablecoins Are Going Mainstream — Fast</a></strong></p>
<h2 class="wp-block-heading">How To Buy CRCL Stock</h2>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in Circle Internet Group&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p><em>Image: Shutterstock</em></p>


CRCL

Circle Internet Group (CRCL) Shares Rally As Trump's Intervention Revives Key Stablecoin Bill

<p>Wells Fargo  analyst Elyse Greenspan   maintains Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with a Equal-Weight and lowers the price target from $116 to $113.</p>


Wells Fargo Maintains Equal-Weight on Prudential Financial, Lowers Price Target to $113

WIIM

STKH

Steakholder shares are trading lower after the company announced the pricing of a $2.5 million offering.

<ul>
<li><i>Additional complete response (CR) observed in patient with multiple tumors</i></li>
<li><i>Confirmed overall response rate (ORR) of 50% in patients with combined positive score (CPS) ≥1, including 50% ORR in patients with low CPS (1-19)</i></li>
<li><i>12-month overall survival of 88% and median overall survival (mOS) of 32 months</i><br /><br />&nbsp;</li>
</ul>
<p>BOSTON, July 16, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=nHu2Z2kEg39yeiyOw9KaWZtbXK6yK153AiWDyXyj-LJbCkXTroe63pjQng79JF_m2r9vtgdCm98Y_vGsiOly4LcXfF7LrMb0jiRWcfpnvQo1oev59hkTG7vku5uJLzYeIq3aj1AQozfte6pklUDIBbcmIAXFabH_ZHU2ofnYzKlQVtvZHyRJlDidYht3LUYwl0-DxL1hnh_we629PWKCVsCv57icDLFlB61Ngs6CAr8y2KrSd3iFJ_g6RZVDWNjtXq3n6oOPfcRvTM0kQXJE2g==">Cue Biopharma, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, today provided a clinical update on its most advanced asset, CUE-101, representative of the CUE-100 series.</p>


Biotech

Reported Earlier: Cue Biopharma Reports 50% Overall Response Rate And 88% 12-Month Survival In CUE-101 Trial For HPV+ Cancers

<p>Wells Fargo  analyst Michael Brown   maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and lowers the price target from $1180 to $1170.</p>


Wells Fargo Maintains Overweight on BlackRock, Lowers Price Target to $1170

Macro Economic Events

Politics

Global

Economics

Bahrain Crown Prince Says Iran Stands To Benefit From Negotiations; President Trump Says Iran Want To Negotiate Badly, We're In No Rush

<p><a href="https://x.com/markjcarney/status/1945508348067262837?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/markjcarney/status/1945508348067262837?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a></p>


Macro Notification

Canada Prime Minister Carney Says  U.S. Trade Deals With Other Countries Will Involve Very High Tariffs, Must Protect Canadian Industries From Secondary Effects; On Softwood Lumber Says Top Priority In Negotiations With U.S., Would Like To Resolve It At Same Time As Other Trade Issues

DPRO

Draganfly shares are trading higher after the company announced its Cammander3 XL UAV has been selected by the Department of Defense for advanced operation initiatives.

Federal Reserve

President Trump, Asked About Firing Powell, Says Highly Unlikely; Unless There's Fraud; I Haven't Drafted A Letter; Raised Concept Of Firing Powell With Lawmakers, Says He's More Conservative Than Them On Firing Powell

CPSH

CPS Technologies shares are trading higher after the company announced it has won a $140K small business innovation research award.

<p>OFG Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OFG#NYSE">OFG</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-07-17. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that OFG Bancorp will report an <strong>earnings per share</strong> (EPS) of $1.05.</p>
<p>OFG Bancorp bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.03, leading to a 2.75% increase in the share price the following trading session.</p>
<p>Here's a look at OFG Bancorp's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>0.96</td>
<td>1.02</td>
<td>0.96</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1</td>
<td>1.09</td>
<td>1</td>
<td>1.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681667_0.png" alt="eps graph" /></p>
<h3>Market Performance of OFG Bancorp's Stock</h3>
<p>Shares of OFG Bancorp were trading at $43.29 as of July 15. Over the last 52-week period, shares are up 1.42%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/OFG/earnings"><strong>To track all earnings releases for OFG Bancorp visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Look Ahead: OFG Bancorp's Earnings Forecast

<p><strong>ManpowerGroup</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) is set to give its latest quarterly earnings report on Thursday, 2025-07-17. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that ManpowerGroup will report an <strong>earnings per share</strong> (EPS) of $0.69. </p>
<p>Anticipation surrounds ManpowerGroup's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS missed by $0.06 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p>
<p>Here's a look at ManpowerGroup's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.50</td>
<td>1</td>
<td>1.29</td>
<td>1.28</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.44</td>
<td>1.02</td>
<td>1.29</td>
<td>1.30</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-19.0%</td>
<td>-1.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681657_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of ManpowerGroup were trading at $42.33 as of July 15. Over the last 52-week period, shares are down 42.36%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Opinions on ManpowerGroup</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on ManpowerGroup.</p>
<p>The consensus rating for ManpowerGroup is Neutral, derived from 4 analyst ratings. An average one-year price target of $47.75 implies a potential 12.8% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Insperity, Upwork and Barrett Business Services, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Insperity, with an average 1-year price target of $70.0, suggesting a potential 65.37% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Upwork, with an average 1-year price target of $18.6, suggesting a potential 56.06% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Barrett Business Services, with an average 1-year price target of $45.0, suggesting a potential 6.31% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary presents essential metrics for Insperity, Upwork and Barrett Business Services, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>ManpowerGroup</td>
<td>Neutral</td>
<td>-7.11%</td>
<td>$698.30M</td>
<td>0.26%</td>
</tr>
<tr>
<td>Insperity</td>
<td>Neutral</td>
<td>3.39%</td>
<td>$310M</td>
<td>47.22%</td>
</tr>
<tr>
<td>Upwork</td>
<td>Neutral</td>
<td>0.93%</td>
<td>$150.90M</td>
<td>6.45%</td>
</tr>
<tr>
<td>Barrett Business Services</td>
<td>Outperform</td>
<td>10.08%</td>
<td>$42.62M</td>
<td>-0.47%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>ManpowerGroup is at the bottom for Revenue Growth and Gross Profit, while at the top for Return on Equity.</p>
<h3>Delving into ManpowerGroup's Background</h3>
<p>ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.</p>
<h3>ManpowerGroup: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Negative Revenue Trend:</strong> Examining ManpowerGroup's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-7.11%</strong> in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> ManpowerGroup's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>0.14%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> ManpowerGroup's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>0.26%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> ManpowerGroup's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.07%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> ManpowerGroup's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.7</strong>.</p>
<p><a href="https://www.benzinga.com/quote/MAN/earnings"><strong>To track all earnings releases for ManpowerGroup visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


An Overview of ManpowerGroup's Earnings

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>American Airlines Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AAL, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 11 uncommon options trades for American Airlines Group.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 45% bullish and 54%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $1,189,794, and 4 are calls, for a total amount of $274,686.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1.0 to $15.0 for American Airlines Group over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for American Airlines Group's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of American Airlines Group's whale trades within a strike price range from $1.0 to $15.0 in the last 30 days. </p>
<h3>American Airlines Group Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681650_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$0.49</td>
<td>$0.42</td>
<td>$0.42</td>
<td>$5.00</td>
<td>$840.0K</td>
<td>156.4K</td>
<td>20.0K</td>
</tr>
<tr>
<td>AAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$11.6</td>
<td>$10.9</td>
<td>$10.9</td>
<td>$1.00</td>
<td>$138.4K</td>
<td>72</td>
<td>80</td>
</tr>
<tr>
<td>AAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.32</td>
<td>$2.21</td>
<td>$2.25</td>
<td>$12.00</td>
<td>$97.4K</td>
<td>14.4K</td>
<td>978</td>
</tr>
<tr>
<td>AAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$15.00</td>
<td>$91.3K</td>
<td>1.1K</td>
<td>6</td>
</tr>
<tr>
<td>AAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.33</td>
<td>$2.28</td>
<td>$2.28</td>
<td>$10.00</td>
<td>$71.6K</td>
<td>18.0K</td>
<td>315</td>
</tr>
</tbody>
</table>
</p>
<h3>About American Airlines Group</h3>
<p>American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.</p>
<p>Following our analysis of the options activities associated with American Airlines Group, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of American Airlines Group</h3>
<ul>
<li>With a trading volume of 30,084,549, the price of AAL is up by 0.99%, reaching $12.29.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 8 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for American Airlines Group</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $12.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on American Airlines Group, which currently sits at a price target of $12.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for American Airlines Group, targeting a price of $12.<br />
&#x2A; An analyst from B of A Securities has decided to maintain their Neutral rating on American Airlines Group, which currently sits at a price target of $12. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for American Airlines Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

Unpacking the Latest Options Trading Trends in American Airlines Group

<p>Webster Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBS#NYSE">WBS</a>) will release its quarterly earnings report on Thursday, 2025-07-17. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Webster Finl to report an <strong>earnings per share</strong> (EPS) of $1.42.</p>
<p>The market awaits Webster Finl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the last quarter, the company reported an EPS missed by $0.08, leading to a 0.84% drop in the share price on the subsequent day.</p>
<p>Here's a look at Webster Finl's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.38</td>
<td>1.35</td>
<td>1.35</td>
<td>1.34</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.30</td>
<td>1.43</td>
<td>1.34</td>
<td>1.26</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>3.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681648_0.png" alt="eps graph" /></p>
<h3>Market Performance of Webster Finl's Stock</h3>
<p>Shares of Webster Finl were trading at $57.91 as of July 15. Over the last 52-week period, shares are up 18.73%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/WBS/earnings"><strong>To track all earnings releases for Webster Finl visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Peek at Webster Finl's Future Earnings

<p>Financial giants have made a conspicuous bullish move on Oscar Health. Our analysis of options history for Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) revealed 20 unusual trades.</p>
<p>Delving into the details, we found 65% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $107,880, and 18 were calls, valued at $675,451.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $3.0 to $20.0 for Oscar Health over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Oscar Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Oscar Health's significant trades, within a strike price range of $3.0 to $20.0, over the past month.</p>
<h3>Oscar Health Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681645_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>OSCR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$5.7</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$18.00</td>
<td>$81.0K</td>
<td>200</td>
<td align="right">150</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.73</td>
<td>$15.00</td>
<td>$73.6K</td>
<td>12.6K</td>
<td align="right">616</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.45</td>
<td>$2.35</td>
<td>$2.45</td>
<td>$20.00</td>
<td>$49.0K</td>
<td>8.1K</td>
<td align="right">383</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$2.25</td>
<td>$2.1</td>
<td>$2.25</td>
<td>$20.00</td>
<td>$45.0K</td>
<td>3.0K</td>
<td align="right">531</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$2.2</td>
<td>$2.05</td>
<td>$2.2</td>
<td>$20.00</td>
<td>$44.0K</td>
<td>3.0K</td>
<td align="right">329</td>
</tr>
</tbody>
</table>
</p>
<h3>About Oscar Health</h3>
<p>Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.</p>
<h3>Present Market Standing of Oscar Health</h3>
<ul>
<li>Currently trading with a volume of 15,876,455, the OSCR's price is down by -0.6%, now at $14.83. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 21 days.</li>
</ul>
<h3>What The Experts Say On Oscar Health</h3>
<p>Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $12.67.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Barclays lowers its rating to Underweight with a new price target of $17.<br />
&#x2A; In a cautious move, an analyst from Wells Fargo downgraded its rating to Underweight, setting a price target of $10.<br />
&#x2A; Reflecting concerns, an analyst from UBS lowers its rating to Sell with a new price target of $11.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Oscar Health options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


OSCR

Decoding Oscar Health's Options Activity: What's the Big Picture?

CREG

Smart Powerr shares are trading lower after the company announced a 1-for-10 rev erse split.

<p>High-rolling investors have positioned themselves bullish on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in PG often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 10 options trades for Procter &amp; Gamble. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 40% bullish and 40% bearish. Among all the options we identified, there was one put, amounting to $111,750, and 9 calls, totaling $606,603.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $165.0 for Procter &amp; Gamble over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale trades within a strike price range from $150.0 to $165.0 in the last 30 days. </p>
<h3>Procter &amp; Gamble Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681639_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$14.95</td>
<td>$14.7</td>
<td>$14.9</td>
<td>$165.00</td>
<td>$111.7K</td>
<td>1.8K</td>
<td align="right">75</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$8.75</td>
<td>$8.5</td>
<td>$8.66</td>
<td>$150.00</td>
<td>$86.6K</td>
<td>437</td>
<td align="right">104</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$8.8</td>
<td>$8.55</td>
<td>$8.64</td>
<td>$150.00</td>
<td>$85.5K</td>
<td>437</td>
<td align="right">204</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$8.75</td>
<td>$8.55</td>
<td>$8.67</td>
<td>$150.00</td>
<td>$84.9K</td>
<td>437</td>
<td align="right">204</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$8.8</td>
<td>$8.6</td>
<td>$8.72</td>
<td>$150.00</td>
<td>$82.7K</td>
<td>437</td>
<td align="right">397</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.</p>
<h3>Present Market Standing of Procter &amp; Gamble</h3>
<ul>
<li>With a trading volume of 2,577,723, the price of PG is down by -0.03%, reaching $152.63.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 13 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Procter &amp; Gamble</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $165.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Evercore ISI Group lowers its rating to In-Line with a new price target of $170.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Procter &amp; Gamble with a target price of $161. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter &amp; Gamble options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Check Out What Whales Are Doing With Procter & Gamble

<p><strong>Simmons First Ntl</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFNC#NASDAQ">SFNC</a>) is set to give its latest quarterly earnings report on Thursday, 2025-07-17. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Simmons First Ntl will report an <strong>earnings per share</strong> (EPS) of $0.40. </p>
<p>The market awaits Simmons First Ntl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS missed by $0.09 in the last quarter, leading to a 3.98% drop in the share price on the following day.</p>
<p>Here's a look at Simmons First Ntl's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.35</td>
<td>0.36</td>
<td>0.33</td>
<td>0.31</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.26</td>
<td>0.39</td>
<td>0.37</td>
<td>0.33</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>-2.0%</td>
<td>-0.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752681638_0.png" alt="eps graph" /></p>
<h3>Market Performance of Simmons First Ntl's Stock</h3>
<p>Shares of Simmons First Ntl were trading at $19.44 as of July 15. Over the last 52-week period, shares are down 6.85%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/SFNC/earnings"><strong>To track all earnings releases for Simmons First Ntl visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SFNC

Simmons First Ntl Earnings Preview

Press Releases

National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2024 Financial Results

National Vision Announces Participation in UBS Global Consumer and Retail Conference

National Vision Awards $12,500 to Three Optometry Students in 10th Annual Scholarship Program

National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors

National Vision Names VML Agency of Record

National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

National Vision Appoints Alex Wilkes as CEO

National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results

National Vision Announces Settlement of 2025 Convertible Senior Notes

National Vision Announces Participation in William Blair Growth Stock Conference

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

BARK

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

MarineMax

Leslies

PetMed Express

Pitanium Limited - Class A Ordinary Shares

Pitanium

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Comments

National Vision Holdings

Unusual Options Activity for

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO